cardiovascular system
• after continuous phenylephrine administration, mice exhibit more severe lung congestion than wild-type mice
|
• cardiomyocytes show disturbed transverse tubule morphology
|
• hearts show reduced left ventricular ejection fraction
|
• echocardiography shows left ventricular dilatation and slightly reduced systolic function in the heart, with increased left ventricular end-diastolic volume and left ventricular end-systolic volume, and reduced left ventricular ejection fraction
|
• mice intraperitoneally injected with epinephrine and caffeine show more frequent episodes of ventricular tachycardia
|
• mice intraperitoneally injected with epinephrine and caffeine show more frequent premature ventricular contractions
|
• cardiomyocytes exhibit changes in calcium dynamics, with reduced amplitude and delayed decay of calcium transients
|
homeostasis/metabolism
• after continuous phenylephrine administration (catecholamine stimulation), mice show higher mortality than wild-type mice
|
mortality/aging
• after continuous phenylephrine administration (catecholamine stimulation), mice show higher mortality than wild-type mice
|
muscle
• cardiomyocytes show disturbed transverse tubule morphology
|
• hearts show reduced left ventricular ejection fraction
|
respiratory system
• after continuous phenylephrine administration, mice exhibit more severe lung congestion than wild-type mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dilated cardiomyopathy 2F | DOID:0081162 |
OMIM:619747 |
J:327046 |